These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14574012)

  • 21. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
    Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
    Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA mutations in the management of breast cancer: the state of the art.
    Narod SA
    Nat Rev Clin Oncol; 2010 Dec; 7(12):702-7. PubMed ID: 20956982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary breast cancer syndromes and clinical implications.
    Majdak-Paredes EJ; Fatah F
    J Plast Reconstr Aesthet Surg; 2009 Feb; 62(2):181-9. PubMed ID: 19027378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic surgery for women at high risk for breast cancer.
    Blanchard DK; Hartmann LC
    Clin Breast Cancer; 2000 Jul; 1(2):127-34; discussion 135. PubMed ID: 11899651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
    Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
    Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer: Genetics and Risk Assessment.
    Tejada-Bergés T
    Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].
    Narod SA; Rodríguez AA
    Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
    Kaufman DJ; Beaty TH; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary breast cancer in Jews.
    Rubinstein WS
    Fam Cancer; 2004; 3(3-4):249-57. PubMed ID: 15516849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls and caveats in BRCA sequencing.
    Bellosillo B; Tusquets I
    Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.
    Einbeigi Z; Bergman A; Meis-Kindblom JM; Flodin A; Bjursell C; Martinsson T; Kindblom LG; Wahlström J; Wallgren A; Nordling M; Karlsson P
    Fam Cancer; 2007; 6(1):35-41. PubMed ID: 16944270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
    Stoppa-Lyonnet D; Caligo M; Eccles D; Evans DG; Haites NE; Hodgson NS; Møller P; Morrison PJ; Steel CM; Vasen HF; Chang-Claude J
    Dis Markers; 1999 Oct; 15(1-3):67-8. PubMed ID: 10595254
    [No Abstract]   [Full Text] [Related]  

  • 35. Practical aspects of genetic counseling in breast cancer: lights and shadows.
    Christinat A; Pagani O
    Breast; 2013 Aug; 22(4):375-82. PubMed ID: 23673076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
    JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.
    Azzollini J; Scuvera G; Bruno E; Pasanisi P; Zaffaroni D; Calvello M; Pasini B; Ripamonti CB; Colombo M; Pensotti V; Radice P; Peissel B; Manoukian S
    Eur J Intern Med; 2016 Jul; 32():65-71. PubMed ID: 27062684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.
    Marchina E; Fontana MG; Speziani M; Salvi A; Ricca G; Di Lorenzo D; Gervasi M; Caimi L; Barlati S
    Oncol Rep; 2010 Dec; 24(6):1661-7. PubMed ID: 21042765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes.
    Smith M; Fawcett S; Sigalas E; Bell R; Devery S; Andrieska N; Winship I
    Fam Cancer; 2008; 7(2):119-24. PubMed ID: 17636421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.